See also this year's filing and all EDGAR filings for this company.
PDF Report 0001708599_2019_Serina_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001708599, Serina Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,853,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,709,000 |
| 2 | PropertyPlantAndEquipmentNet | 90,000 |
| 3 | remainder_Assets | 19,000 |
| 4 | LiabilitiesCurrent | 0 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,440,000 |
| 7 | CostOfGoodsAndServicesSold | 364,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,647,000 |
| 9 | ResearchAndDevelopmentExpense | 5,830,000 |
| 10 | remainder_Expenses | 800,000 |
| 11 | remainder_Revenues | 1,396,000 |
| 12 | remainder_NetIncome | 3,514,000 |
| 13 | remainder_ComprehensiveNetIncome | 15,532,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 10,671,000 |
| 1 | Liabilities | 2,440,000 |
| 2 | Expenses | 12,641,000 |
| 3 | Revenues | 1,396,000 |
| 4 | StockholdersEquity | 8,231,000 |
| 5 | NetIncome | -7,731,000 |
| 6 | ComprehensiveNetIncome | 35,000 |
| 7 | BaseVar | 23,097,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.74 |
| 9 | EconomicCapitalRatio | 3.52 |